Abstract
A recent National Academies report articulates a path forward for research, ethics, and governance of clinical applications involving genome editing. In light of recent human embryo editing developments, scientists and stakeholders from all nations should cooperate to take advantage of this historic opportunity for medicine and also basic human biology. A recent National Academies report articulates a path forward for research, ethics, and governance of clinical applications involving genome editing. In light of recent human embryo editing developments, scientists and stakeholders from all nations should cooperate to take advantage of this historic opportunity for medicine and also basic human biology.
Original language | English (US) |
---|---|
Pages (from-to) | 423-426 |
Number of pages | 4 |
Journal | Cell Stem Cell |
Volume | 21 |
Issue number | 4 |
DOIs |
|
State | Published - Oct 5 2017 |
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology